DoD can't continue to ignore this conflict of interest that arises when a company owns both a PBM and a pharmacy. That has ...

Express Scripts — one of the largest pharmacy benefit managers in the country — has notched a major partnership with independent pharmacies, amid contentious relations between the two industries. The ...

If you've spent years managing your health across MyChart, Express Scripts, and WellCare, you know the frustration of disjointed alerts and opaque prior authorization processes. But as of May 2026, ...

Express Scripts, the pharmacy benefits services business of The Cigna Group’s Evernorth, is making it easier for people to access a broader range of care services at independent pharmacies A new ...

Another major pharmacy benefit manager is adding Humira biosimilars to its formulary beginning next year. Express Scripts, which is part of Cigna's Evernorth subsidiary, said Monday that it will add ...

The potential deal comes about a year and a half after the FTC first brought the case against Express Scripts, CVS’ Caremark and UnitedHealth’s Optum Rx. If approved, the agreement would mark the ...

The Meta logo and logos of Facebook, Instagram, WhatsApp, Messenger and Threads are screened on a mobile phone for illustration photo in Krakow, Poland on Jan. 25, 2025 (Beata Zawrzel / NurPhoto via ...

The Seventh Amendment entitles litigants to a jury trial unless the claim would have been heard, and the remedy awarded, by ...

Express Scripts Holding, a pharmacy benefit manager that negotiates drug prices for many health plans, will launch a formulary with lower list price drugs in an effort to reduce reliance on rebates ...

Express Scripts (ESRX) confirms that it has completed its previously announced $29.1B acquisition of Medco Health (MHS) today. Following consummation of the acquisition, each share of pre-closing ...

A federal appeals court granted Express Scripts Inc.‘s petition for a jury trial in a case from 120 cities, towns, and ...

Pharmacy benefit manager Express Scripts, part of Cigna's Evernorth subsidiary, will be adding Humira biosimilars to its formulary in 2023 as preferred products, which will be available to patients ...